Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | KCNA5 | P22460 | 7/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6163878 | 1.00 | KCNH2 (0.51) | KCNH2KCNA5MAPTNPSR1KMT2A | |
| SCHEMBL6163891 | 1.00 | KCNH2 (0.51) | KCNH2KCNA5MAPTNPSR1KMT2A | |
| SCHEMBL6172086 | 0.93 | KCNH2 (0.53) | KCNH2KCNA5MAPTNPSR1KMT2A | |
| SCHEMBL6172074 | 0.93 | KCNH2 (0.53) | KCNH2KCNA5MAPTNPSR1KMT2A | |
| SCHEMBL6172081 | 0.93 | KCNH2 (0.53) | KCNH2KCNA5MAPTNPSR1KMT2A | |
| SCHEMBL6165735 | 0.92 | KCNH2 (0.52) | KCNH2KCNA5MAPTNPSR1KMT2A | |
| SCHEMBL6165727 | 0.92 | KCNH2 (0.52) | KCNH2KCNA5MAPTNPSR1KMT2A | |
| SCHEMBL6165740 | 0.92 | KCNH2 (0.52) | KCNH2KCNA5MAPTNPSR1KMT2A | |
| SCHEMBL6167849 | 0.91 | KCNH2 (0.51) | KCNH2KCNA5MAPTNPSR1KMT2A | |
| SCHEMBL6167833 | 0.91 | KCNH2 (0.51) | KCNH2KCNA5MAPTNPSR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1212314-B1 | BENZOPYRAN DERIVATIVE | NISSAN CHEMICAL IND LTD (JP) | 2005-11-30 | — | — | EP | disclosed |
| US-6589983-B1 | Antiarrhythmic agents having the prolongation effect on the functional refractory period as a main function | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2003-07-08 | — | — | US | disclosed |